Unaudited Condensed Statements of Changes in Shareholders’ Deficit - USD ($)		Ordinary shares		Additional paid-in capital	Accumulated other comprehensive income	Accumulated deficit	Total
Balance at Dec. 31, 2022	[1]	$ 374		$ 24,626		$ (3,766)	$ 21,234
Balance (in Shares) at Dec. 31, 2022	[1]	3,737,500
Net income (loss)						(4,032)	(4,032)
Balance at Mar. 31, 2023	[1]	$ 374		24,626		(7,798)	$ 17,202
Balance (in Shares) at Mar. 31, 2023		3,737,500	[1]				4,416,075
Balance at Dec. 31, 2023		$ 442			$ 1,521,171	(3,659,998)	$ (2,138,385)
Balance (in Shares) at Dec. 31, 2023		4,416,075					4,416,075
Accretion of carrying value to redemption value						(2,011,447)	$ (2,011,447)
Net income (loss)						3,266,193	3,266,193
Realized gain on available held for sale securities					(1,521,171)		(1,521,171)
Balance at Mar. 31, 2024		$ 442				$ (2,405,252)	$ (2,404,810)
Balance (in Shares) at Mar. 31, 2024		4,416,075					4,416,075

[1] Includes up to an aggregate of 487,500 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part (see Note 5). As a result of the underwriters’ full exercise of their over-allotment option on July 27, 2023, no founder shares are currently subject to forfeiture.